These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Single-brand dual-chamber discriminators to prevent inappropriate shocks in patients implanted with prophylactic implantable cardioverter defibrillators: a propensity-weighted comparison of single- and dual-chamber devices. Briongos-Figuero S, Sánchez A, Pérez ML, Martínez-Ferrer JB, García E, Viñolas X, Arenal Á, Alzueta J, Basterra N, Rodríguez A, Lozano I, Muñoz-Aguilera R. J Interv Card Electrophysiol; 2019 Apr; 54(3):267-275. PubMed ID: 30523511 [Abstract] [Full Text] [Related]
3. A prospective randomized trial of single- or dual-chamber implantable cardioverter-defibrillators to minimize inappropriate shock risk in primary sudden cardiac death prevention. Friedman PA, Bradley D, Koestler C, Slusser J, Hodge D, Bailey K, Kusumoto F, Munger TM, Militanu A, Glikson M. Europace; 2014 Oct; 16(10):1460-8. PubMed ID: 24928948 [Abstract] [Full Text] [Related]
6. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study. Kolb C, Sturmer M, Sick P, Reif S, Davy JM, Molon G, Schwab JO, Mantovani G, Dan D, Lennerz C, Borri-Brunetto A, Babuty D. JACC Heart Fail; 2014 Dec; 2(6):611-9. PubMed ID: 25282033 [Abstract] [Full Text] [Related]
7. Mortality and appropriate and inappropriate therapy in patients with ischaemic heart disease and implanted cardioverter-defibrillators for primary prevention: data from the Danish ICD Register. Weeke P, Johansen JB, Jørgensen OD, Nielsen JC, Møller M, Videbæk R, Højgaard MV, Riahi S, Jacobsen PK. Europace; 2013 Aug; 15(8):1150-7. PubMed ID: 23407630 [Abstract] [Full Text] [Related]
8. Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators. Bansal N, Szpiro A, Masoudi F, Greenlee RT, Smith DH, Magid DJ, Gurwitz JH, Reynolds K, Tabada GH, Sung SH, Dighe A, Cassidy-Bushrow A, Garcia-Montilla R, Hammill S, Hayes J, Kadish A, Sharma P, Varosy P, Vidaillet H, Go AS. Heart; 2017 Apr; 103(7):529-537. PubMed ID: 27742796 [Abstract] [Full Text] [Related]
18. Gender and outcomes after primary prevention implantable cardioverter-defibrillator implantation: Findings from the National Cardiovascular Data Registry (NCDR). Russo AM, Daugherty SL, Masoudi FA, Wang Y, Curtis J, Lampert R. Am Heart J; 2015 Aug 01; 170(2):330-8. PubMed ID: 26299231 [Abstract] [Full Text] [Related]
19. Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry. Borne RT, Peterson PN, Greenlee R, Heidenreich PA, Wang Y, Curtis JP, Tzou WS, Varosy PD, Kremers MS, Masoudi FA. Circulation; 2014 Sep 02; 130(10):845-53. PubMed ID: 25095884 [Abstract] [Full Text] [Related]
20. Long-Term Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults. Bettin M, Larbig R, Rath B, Fischer A, Frommeyer G, Reinke F, Köbe J, Eckardt L. JACC Clin Electrophysiol; 2017 Dec 26; 3(13):1499-1506. PubMed ID: 29759830 [Abstract] [Full Text] [Related] Page: [Next] [New Search]